Literature DB >> 22432792

Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients.

Nader Dbouk1, Samir Parekh.   

Abstract

BACKGROUND AND AIMS: Disease recurrence following transplantation occurs in 20-45% of patients with autoimmune hepatitis (AIH). Factors associated with an increased risk of recurrence include human leukocyte antigen (HLA) DR3 and HLA DR4 positivity, inadequate immunosuppression, and severity of inflammation in the native liver. Titers of several autoantibodies can be elevated in patients with AIH, including antinuclear antibody (ANA) and antismooth muscle antibody (SMA); however, it is unclear whether or not the degree of elevation influences the risk of disease recurrence following transplantation.
METHODS: We conducted a retrospective study to evaluate the potential impact of pretransplant titers on post-transplant outcomes for patients with AIH. Sixty-three patients with AIH who underwent 72 liver transplants between 1 January 1989 and 1 January 2009 were included, with a median follow up of 10 months. Patients were divided into group A (ANA or SMA ≥ 1:160) and group B (titers ≤ 1:160).
RESULTS: There was no significant difference in the recurrence rates or death between patients in groups A and B, respectively. Only race appeared to impact outcomes, with African American patients having a higher incidence of death and recurrent disease post-transplant compared to other ethnicities.
CONCLUSIONS: Based on our findings, pretransplant ANA and SMA levels do not appear to impact recurrence rates or outcomes following liver transplantation for AIH.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22432792      PMCID: PMC3388173          DOI: 10.1111/j.1440-1746.2012.07125.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  24 in total

1.  Liver transplantation for autoimmune hepatitis: rejection and recurrence.

Authors:  S Narumi; K Hakamada; M Sasaki; C E Freise; P G Stock; J P Roberts; N L Ascher
Journal:  Transplant Proc       Date:  1999-08       Impact factor: 1.066

2.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  Albert J Czaja; Deborah K Freese
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

3.  Allograft rejection after liver transplantation for autoimmune liver diseases.

Authors:  M Hayashi; E B Keeffe; S M Krams; O M Martinez; O N Ojogho; S K So; G Garcia; J C Imperial; C O Esquivel
Journal:  Liver Transpl Surg       Date:  1998-05

4.  Liver transplantation for autoimmune hepatitis in Peru: outcomes and recurrence.

Authors:  Martín Padilla; Rosario Mayorga; Félix Carrasco; Tayana Bedregal; Fernando Bobadilla; Carlos Rondón; José Chaman
Journal:  Ann Hepatol       Date:  2012 Mar-Apr       Impact factor: 2.400

5.  Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.

Authors:  Ernesto P Molmenti; George J Netto; Natalie G Murray; Douglas M Smith; Hebe Molmenti; Jeffrey S Crippin; Tyrone C Hoover; Ghapjoong Jung; Shigeru Marubashi; Edmund Q Sanchez; Brian Gogel; Marlon F Levy; Robert M Goldstein; Carlos G Fasola; Thomas A Gonwa; Goran B Klintmalm
Journal:  Liver Transpl       Date:  2002-06       Impact factor: 5.799

6.  Recurrence of autoimmune hepatitis after liver transplantation.

Authors:  P Milkiewicz; S G Hubscher; G Skiba; M Hathaway; E Elias
Journal:  Transplantation       Date:  1999-07-27       Impact factor: 4.939

7.  Liver transplantation for autoimmune hepatitis: a long-term pathologic study.

Authors:  G Ayata; F D Gordon; W D Lewis; E Pomfret; J J Pomposelli; R L Jenkins; U Khettry
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

8.  Long-term outcome of liver transplantation for autoimmune hepatitis.

Authors:  Arndt Vogel; Eyk Heinrich; Matthias J Bahr; Kinan Rifai; Peer Flemming; Michael Melter; Juergen Klempnauer; Björn Nashan; Michael P Manns; Christian P Strassburg
Journal:  Clin Transplant       Date:  2004-02       Impact factor: 2.863

Review 9.  Transplantation for autoimmune hepatitis.

Authors:  James Neuberger
Journal:  Semin Liver Dis       Date:  2002-11       Impact factor: 6.115

10.  A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.

Authors:  J-C Duclos-Vallée; M Sebagh; K Rifai; C Johanet; E Ballot; C Guettier; V Karam; M Hurtova; C Feray; M Reynes; H Bismuth; D Samuel
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

View more
  6 in total

Review 1.  Autoimmune hepatitis.

Authors:  Farhad Sahebjam; John M Vierling
Journal:  Front Med       Date:  2015-03-06       Impact factor: 4.592

Review 2.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.

Authors:  Nikolaos K Gatselis; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 3.  Posttransplant considerations in autoimmune liver disease: Recurrence of disease and de novo.

Authors:  Alexis Gumm; Antonio Perez-Atayde; Andrew Wehrman
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-10-10

4.  Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid.

Authors:  Sanjaya K Satapathy; Ollie D Jones; Jason M Vanatta; Faisal Kamal; Satish K Kedia; Yu Jiang; Satheesh P Nair; James D Eason
Journal:  Transplant Direct       Date:  2017-06-23

5.  Positive autoantibodies in living liver donors.

Authors:  Joyce Loh; Koji Hashimoto; Choon Hyuck David Kwon; Masato Fujiki; Jamak Modaresi Esfeh
Journal:  World J Hepatol       Date:  2022-09-27

6.  HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation.

Authors:  Marshall McCabe; Natalia Rush; Craig Lammert; Kavish R Patidar; Lauren Nephew; Romil Saxena; Burcin Ekser; James Salven; Chandrashekhar Kubal; Marwan Ghabril
Journal:  Transplant Direct       Date:  2021-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.